Rheos Medicines' Series A Round

Rheos Medicines raised a round of funding on March 22, 2018. Investors include Third Rock Ventures.

Rheos Medicines is a Cambridge, Mass.-based is a biopharmaceutical company developing medicines that modulate metabolic pathways in immune cells to treat disease. Rheos is developing a biomarker and d…

Articles about Rheos Medicines' Series A Round: